◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

AGIOS PHARMACEUTICALS, INC.

CIK: 1439222 SIC: 2834
$54.03M
Revenue
$-412.78M
Net Income
88.26%
Gross Margin
-873.87%
Op. Margin
$-679.80M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 38 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $19.97M $12.88M $12.46M $8.73M $10.73M $8.96M $8.62M
Revenue Growth % (YoY) 86.1% 43.7% 44.6% nan% nan% nan% nan%
Cost of Revenue $1.88M $1.68M $1.70M $1.08M $1.26M $783.00K $1.50M
+ Gross Profit $18.09M $11.20M $10.75M $7.64M $9.47M $8.18M $7.12M
Gross Margin % 90.6% 87.0% 86.3% 87.6% 88.3% 91.3% 82.6%
Operating Expenses $141.54M $129.75M $139.51M $115.36M $135.77M $111.78M $114.43M
Research & Development $88.06M $86.80M $91.94M $72.74M $82.81M $72.45M $77.40M
Selling General & Admin $51.61M $41.27M $45.87M $41.53M $51.70M $38.54M $35.54M
+ Operating Income $-121.58M $-116.87M $-127.06M $-106.63M $-125.04M $-102.81M $-105.82M
Operating Margin % -608.9% -907.4% -1020.1% -1222.0% -1165.3% -1146.9% -1228.3%
Other Income/Expense $113.00K $67.00K $523.00K $1.25M $1.62M $1.65M $1.58M
Income Before Tax $-109.06M $-103.43M - - $-105.40M $1.00B -
Income Tax Expense $-1.02M - - - $-8.88M $53.12M -
+ Net Income $-108.04M $-103.43M $-112.02M $-89.29M $-96.52M $947.91M $-96.12M
Net Margin % -541.1% -803.1% -899.4% -1023.3% -899.6% 10574.7% -1115.7%
Basic EPS -1.85 -1.78 -1.93 -1.55 -1.72 16.65 -1.69
Diluted EPS -1.85 -1.78 -1.93 -1.55 -1.74 16.22 -1.69
Basic Shares Outstanding - 58.1M 57.9M 57.5M 98K 56.9M 56.8M
Diluted Shares Outstanding - 58.1M 57.9M 57.5M 308K 58.4M 56.8M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $89.13M $92.71M $80.87M $78.96M $76.25M $253.73M $84.52M
Inventory $32.92M $32.03M $30.85M $29.61M $27.62M $26.43M $23.94M
Other Current Assets $44.13M $43.19M $44.69M $42.29M $40.16M $39.88M $34.54M
Total Current Assets $942.05M $1.03B $1.02B $968.62M $965.60M $1.07B $632.13M
Property Plant & Equipment $10.78M $10.68M $10.58M $11.07M $11.68M $11.82M $12.73M
Other Non-current Assets $3.93M $3.93M $3.94M $4.72M $4.72M $4.06M $4.06M
Total Assets $1.30B $1.39B $1.47B $1.56B $1.66B $1.79B $773.06M
Accounts Payable $18.36M $19.55M $17.53M $13.73M $16.64M $17.14M $10.04M
Accrued Liabilities $45.46M $37.22M $35.29M $20.76M $46.86M $33.31M $36.74M
Total Current Liabilities $82.21M $74.76M $70.41M $52.37M $81.16M $119.45M $62.64M
Other Non-current Liabilities $90.00K $90.00K $101.00K $880.00K $880.00K $1.16M $1.16M
Total Liabilities $104.11M $101.38M $101.68M $88.99M $122.24M $165.12M $112.55M
Retained Earnings $-561.71M $-453.67M $-350.23M $-238.21M $-148.92M $-52.40M $-1.00B
Treasury Stock $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M
Total Stockholders Equity $1.19B $1.28B $1.37B $1.47B $1.54B $1.63B $660.51M
Total Liabilities & Equity $1.30B $1.39B $1.47B $1.56B $1.66B $1.79B $773.06M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-108.04M $-103.43M $-201.31M $-89.29M $-96.52M $947.91M $-96.12M
Stock-based Compensation $14.12M $38.43M $26.05M $11.36M $10.90M $31.94M $20.80M
Change in Receivables $5.55M $920.00K $877.00K $-765.00K $991.00K $308.00K $952.00K
Change in Inventory $886.00K $4.42M $3.23M $1.99M $1.19M $7.35M $4.86M
Change in Payables $-1.15M $2.89M $1.08M $-2.82M $-756.00K $7.36M $268.00K
Operating Cash Flow $-96.21M $-276.76M $-188.61M $-111.49M $-133.17M $-256.67M $-172.46M
Capital Expenditure $1.12M $3.20M $1.64M $766.00K $967.00K $718.00K $299.00K
Investing Cash Flow $90.08M $287.11M $191.55M $112.59M $-49.16M $412.60M $161.81M
Financing Cash Flow $2.56M $6.12M $1.68M $1.62M $4.84M $9.60M $6.96M
Net Change in Cash $-3.58M $16.46M $4.62M $2.72M $-177.48M $165.53M $-3.69M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $12.88M - $34.06M -
Cost of Revenue $1.68M - $4.47M -
Operating Expenses $129.75M - $384.62M -
Research & Development $86.80M - $251.48M -
Selling General & Admin $41.27M - $128.67M -
Operating Income $-116.87M - $-350.55M -
Other Income/Expense $67.00K - $1.84M -
Income Before Tax $-103.43M - $-304.74M -
Income Tax Expense - - - -
Net Income $-103.43M $-96.12M $-304.74M -
Basic EPS -1.78 - -5.27 -
Diluted EPS -1.78 - -5.27 -
Basic Shares Outstanding $58.14M - $57.85M -
Diluted Shares Outstanding $58.14M - $57.85M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $92.71M $76.25M
Inventory $32.03M $27.62M
Other Current Assets $43.19M $40.16M
Total Current Assets $1.03B $965.60M
Property Plant & Equipment $10.68M $11.68M
Other Non-current Assets $3.93M $4.72M
Total Assets $1.39B $1.66B
Accounts Payable $19.55M $16.64M
Accrued Liabilities $37.22M $46.86M
Total Current Liabilities $74.76M $81.16M
Other Non-current Liabilities $90.00K $880.00K
Total Liabilities $101.38M $122.24M
Retained Earnings $-453.67M $-148.92M
Treasury Stock $802.49M $802.49M
Total Stockholders Equity $1.28B $1.54B
Total Liabilities & Equity $1.39B $1.66B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-103.43M $-96.12M $-304.74M -
Stock-based Compensation - - $38.43M -
Change in Receivables - - $920.00K -
Change in Inventory - - $4.42M -
Change in Payables - - $2.89M -
Operating Cash Flow - - $-276.76M -
Capital Expenditure - - $3.20M -
Investing Cash Flow - - $287.11M -
Financing Cash Flow - - $6.12M -
Net Change in Cash - - $16.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...